The immunogenicity of 7-valent pneumococcal conjugate vaccine (PCV7) in adult bone marrow transplant patients

Br J Haematol. 2018 Jun;181(6):860-863. doi: 10.1111/bjh.14725. Epub 2017 May 3.

Authors

C Raina MacIntyre^{1

2}, Anthea L Katelaris¹, Iman Ridda³, Abrar A Chughtai¹, Aye Moa¹, Michelle Barnes¹, Masrura Kabir⁴, Kenneth Bradstock⁵

Affiliations

¹ School of Public Health and Community Medicine, Faculty of Medicine, University of New South Wales, Randwick, Australia.
² College of Public Service and Community Solutions, Arizona State University, Tempe, AZ, USA.
³ Public Health, Health Administration and Health Sciences, Tennessee State University, Nashville, TN, USA.
⁴ Westmead Breast Cancer Institute, Westmead Hospital, Sydney, Australia.
⁵ University of Sydney, Sydney, Australia.

PMID: 28466975
DOI: 10.1111/bjh.14725

No abstract available

Keywords: bone marrow transplant; immune-compromised; pneumococcal vaccine.

Publication types

Letter
Randomized Controlled Trial
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Allografts
Bone Marrow Transplantation*
Female
Heptavalent Pneumococcal Conjugate Vaccine / administration & dosage*
Heptavalent Pneumococcal Conjugate Vaccine / immunology*
Humans
Immunogenicity, Vaccine*
Male
Pilot Projects

Substances

Heptavalent Pneumococcal Conjugate Vaccine

Associated data

ANZCTR/ACTRN12605000773639